Roberto Nani

1.0k total citations · 1 hit paper
18 papers, 656 citations indexed

About

Roberto Nani is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Epidemiology. According to data from OpenAlex, Roberto Nani has authored 18 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Roberto Nani's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), MRI in cancer diagnosis (2 papers) and Renal cell carcinoma treatment (2 papers). Roberto Nani is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), MRI in cancer diagnosis (2 papers) and Renal cell carcinoma treatment (2 papers). Roberto Nani collaborates with scholars based in Italy, United States and Germany. Roberto Nani's co-authors include Irene Bargellini, Rita Golfieri, Roberto Cioni, Alessandro Cucchetti, Daniele Gasparini, Andrea Doriguzzi Breatta, G Gandini, Carlo Bartolozzi, Matteo Renzulli and Franco Trevisani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and British Journal of Cancer.

In The Last Decade

Roberto Nani

13 papers receiving 647 citations

Hit Papers

Randomised controlled trial of doxorubicin-eluting beads ... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Nani Italy 10 505 209 200 126 111 18 656
Andrea Doriguzzi Breatta Italy 8 510 1.0× 252 1.2× 206 1.0× 113 0.9× 109 1.0× 14 589
Leigh Casadaban United States 15 387 0.8× 229 1.1× 303 1.5× 105 0.8× 74 0.7× 25 664
Tianfu Wen China 18 529 1.0× 260 1.2× 351 1.8× 110 0.9× 137 1.2× 40 758
S. Metrangolo Italy 10 362 0.7× 186 0.9× 161 0.8× 120 1.0× 94 0.8× 16 548
J K Han South Korea 6 585 1.2× 241 1.2× 266 1.3× 204 1.6× 78 0.7× 10 790
Chie Tatsumi Japan 13 534 1.1× 390 1.9× 127 0.6× 54 0.4× 83 0.7× 16 677
Taku Yasumoto Japan 10 223 0.4× 135 0.6× 243 1.2× 140 1.1× 70 0.6× 35 483
Zaibo Jiang China 16 443 0.9× 258 1.2× 381 1.9× 87 0.7× 39 0.4× 56 748
Wong Hoi She Hong Kong 16 365 0.7× 182 0.9× 414 2.1× 268 2.1× 55 0.5× 66 800
Masumi Kadoya Japan 8 358 0.7× 156 0.7× 241 1.2× 146 1.2× 59 0.5× 13 546

Countries citing papers authored by Roberto Nani

Since Specialization
Citations

This map shows the geographic impact of Roberto Nani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Nani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Nani more than expected).

Fields of papers citing papers by Roberto Nani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Nani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Nani. The network helps show where Roberto Nani may publish in the future.

Co-authorship network of co-authors of Roberto Nani

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Nani. A scholar is included among the top collaborators of Roberto Nani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Nani. Roberto Nani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fiorentini, Giammaria, Donatella Sarti, Andrea Mambrini, et al.. (2025). Locoregional Hyperthermia in Cancer Treatment: A Narrative Review with Updates and Perspectives. SHILAP Revista de lepidopterología. 5(2). 26–26.
2.
Fiorentini, Giammaria, Donatella Sarti, Andrea Mambrini, et al.. (2023). Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study. World Journal of Clinical Oncology. 14(6). 215–226. 10 indexed citations
3.
Fiorentini, Giammaria, Donatella Sarti, M Nardella, et al.. (2021). Transarterial Chemoembolization Alone or Followed by Bevacizumab for Treatment of Colorectal Liver Metastases. SHILAP Revista de lepidopterología. 9(1). HEP40–HEP40. 3 indexed citations
4.
Fiorentini, Giammaria, Donatella Sarti, Roberto Nani, et al.. (2020). Updates of colorectal cancer liver metastases therapy: review on DEBIRI. SHILAP Revista de lepidopterología. 7(1). HEP16–HEP16. 29 indexed citations
5.
Fiorentini, Giammaria, Donatella Sarti, Carlo Milandri, et al.. (2019). Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients. Integrative Cancer Therapies. 18. 1871096937–1871096937. 37 indexed citations
6.
Nani, Roberto, et al.. (2018). [OA098] Patient dose monitoring in interventional radiology. Physica Medica. 52. 38–38.
7.
Lucà, Maria Grazia, Roberto Nani, Melanie Schranz, et al.. (2018). Treatment of Hepatocellular Carcinoma: A Cost Analysis Of Yttrium-90 Transarterial Radioembolization Versus Sorafenib. Future Oncology. 14(8). 727–735. 4 indexed citations
8.
Pecorelli, Anna, et al.. (2017). MRI detection of soleus muscle injuries in professional football players. Skeletal Radiology. 46(11). 1513–1520. 14 indexed citations
9.
Cascella, Tommaso, Antonio Facciorusso, Roberto Nani, et al.. (2017). Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma. World Journal of Radiology. 9(5). 245–245. 23 indexed citations
10.
Pecorelli, Anna, Roberto Nani, D. Pinelli, et al.. (2017). Validation of Liver Imaging Reporting and Data System (LI-RADS) Version 2014. Digestive and Liver Disease. 49(1). e49–e49.
11.
Golfieri, Rita, Emanuela Giampalma, Matteo Renzulli, et al.. (2014). Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. British Journal of Cancer. 111(2). 255–264. 432 indexed citations breakdown →
12.
Regazzoni, Daniele, Caterina Rizzi, & Roberto Nani. (2011). A TRIZ-based approach to manage innovation and intellectual property. International Journal of Technology Management. 55(3/4). 274–274. 6 indexed citations
13.
Nani, Roberto & Daniele Regazzoni. (2011). Practice-based methodology for effectively modeling and documenting search, protection and innovation. Procedia Engineering. 9. 665–673.
14.
Giorgio, Massimo De, Stefano Vezzoli, Eric Cohen, et al.. (2010). Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transplantation. 16(4). 503–512. 34 indexed citations
15.
Regazzoni, Daniele & Roberto Nani. (2008). TRIZ-Based Patent Investigation by Evaluating Inventiveness.. Aisberg (University of Bergamo). 247–258.
16.
Bonini, G, et al.. (2007). Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients. Journal of Ultrasound. 10(2). 99–106. 30 indexed citations
17.
Alberti, Daniele, Chiara Locatelli, Roberto Nani, et al.. (2002). Percutaneous transhepatic alcoholization: a new therapeutic strategy in children with chronic granulomatous disease and liver abscess. The Pediatric Infectious Disease Journal. 21(11). 1081–1083. 9 indexed citations
18.
Ruggenenti, Piero, Lidia Mosconi, Simona Bruno, et al.. (2001). Post-transplant renal artery stenosis: The hemodynamic response to revascularization. Kidney International. 60(1). 309–318. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026